- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Society of Breast Imaging Cancels 2020 Conference
The Society of Breast Imaging (SBI) announced it has canceled its annual symposium with the American College of Radiology due to concerns over the growing COVID-19 outbreak. The meeting had been planned for April 16-19 in Denver.
"Protecting the health and well-being of all attendees is our greatest concern," said SBI President Margarita L. Zuley, M.D., in a written statement. "Canceling the Symposium required much discussion and deep consideration. It was a decision we came to reluctantly."
The organization made its decision after reviewing the World Health Organization's evaluations, as well as the ongoing amount of research being published on the impact of the virus. Full refunds will be made available to all registered attendees over the next few weeks, according to the press announcement.
There are no plans to reschedule the meeting for later this year. Instead, the next meeting is planned for April 8-11, 2021, in Savannah, Ga.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
